Enhancing inclusivity in clinical trials: Model‐informed drug development for pregnant individuals in the era of personalized medicine.

MLA

Dallmann, André, et al. “Enhancing Inclusivity in Clinical Trials: Model‐informed Drug Development for Pregnant Individuals in the Era of Personalized Medicine.” CPT: Pharmacometrics & Systems Pharmacology, vol. 13, no. 11, Nov. 2024, pp. 1824–29. EBSCOhost, https://doi.org/10.1002/psp4.13218.

APA

Dallmann, A., Bonate, P. L., Burnham, J., George, B., Yao, L., & Knöchel, J. (2024). Enhancing inclusivity in clinical trials: Model‐informed drug development for pregnant individuals in the era of personalized medicine. CPT: Pharmacometrics & Systems Pharmacology, 13(11), 1824–1829. https://doi.org/10.1002/psp4.13218

Chicago

Dallmann, André, Peter L. Bonate, Janelle Burnham, Blessy George, Lynne Yao, and Jane Knöchel. 2024. “Enhancing Inclusivity in Clinical Trials: Model‐informed Drug Development for Pregnant Individuals in the Era of Personalized Medicine.” CPT: Pharmacometrics & Systems Pharmacology 13 (11): 1824–29. doi:10.1002/psp4.13218.